Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 24, 2018 06:11 ET | Source: Emergent BioSolutions

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine

OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus...
May 10, 2018 16:50 ET | Source: Emergent BioSolutions

Emergent BioSolutions to Hold Annual Meeting of Stockholders on Thursday, May 24, 2018 at 9:00 AM EDT; Webcast Will Be Available

GAITHERSBURG, Md., May 10, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 24, 2018 beginning at...
May 03, 2018 16:30 ET | Source: Emergent BioSolutions

Emergent BioSolutions Reports First Quarter 2018 Financial Results

Reaffirms full year 2018 financial forecast and operational goalsProvides Q2 2018 revenue forecast of $205M-$230M GAITHERSBURG, Md., May 03, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions...
April 19, 2018 06:30 ET | Source: Emergent BioSolutions

Emergent BioSolutions to Release First Quarter 2018 Financial Results and Conduct a Conference Call on May 3, 2018

GAITHERSBURG, Md., April 19, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 3, 2018 at 5:00 pm (Eastern Time) to discuss the financial...
April 12, 2018 06:30 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries

GAITHERSBURG, Md., April 12, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market...
March 26, 2018 16:30 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy

GAITHERSBURG, Md., March 26, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced executive management changes that continue to align its organizational structure to its...
March 22, 2018 16:30 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Implement Stock Repurchase Program for up to $50 Million of Its Common Stock

GAITHERSBURG, Md., March 22, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that its Board of Directors has authorized the company’s management to implement a stock...
February 28, 2018 06:45 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Awarded One-Year CDC Contract Valued at $26 Million for Vaccinia Immune Globulin Program

GAITHERSBURG, Md., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced a contract award by the Centers for Disease Control and Prevention (CDC) valued at $26...
February 26, 2018 16:15 ET | Source: Emergent Biosolutions, Inc.; Valneva SE

Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus

GAITHERSBURG, Md. and LYON, France, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) and Valneva SE (Euronext Paris:VLA) today announced the initiation of a Phase 1 clinical...
February 22, 2018 16:46 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2017 Financial Results

Reaffirms full year 2018 forecast and 2020 goalsRevises 1Q 2018 forecast GAITHERSBURG, Md., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for...